MedPath

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study

Conditions
NAFLD
Cardiovascular Diseases
Registration Number
NCT03534908
Lead Sponsor
Wuhan University
Brief Summary

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world. NAFLD is associated with a lot of comorbidity, such as diabetes, metabolic syndrome, coronary heart disease and chronic kidney diseases. However, the correlation between the NAFLD and cardiovascular disease (CVD) events remains controversial. This study is an observational study based on a big retrospective cohort in china to explore the prevalence of NAFLD in China, the risk factors associated with NAFLD, as well as whether patients with NAFLD are more prone to experience CVDs and CVD events.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
5000000
Inclusion Criteria
  • males or females aged 18-75
Exclusion Criteria
  • malignancy except primary liver cancer
  • pregnancy or breastfeeding
  • liver diseases of other etiology including hepatitis C virus infection ,autoimmune hepatitis,Wilson's disease,hemachromatosis,drug-induced hepatitis,parenteral nutrition
  • excessive alcohol consumption
  • cases missing crucial data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the prevalence of NAFLD in ChinaJune,2020
Secondary Outcome Measures
NameTimeMethod
to indicate the prevalence of CVDs and CVD events in people with and without NAFLDOctober,2020
the risk factors associated with NAFLDAugust,2020

Trial Locations

Locations (1)

Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath